Page last updated: 2024-08-24

5-methylcytosine and Cardiovascular Diseases

5-methylcytosine has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angeles, E; Cabrera, G; Cetina, L; Chanona-Vilchis, J; Chavez-Blanco, A; Duenas-González, A; Perez-Cardenas, E; Revilla-Vazquez, A; Sandoval, K; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Zambrano, P	1

Trials

1 trial(s) available for 5-methylcytosine and Cardiovascular Diseases

Article	Year
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC cancer, 2005, Apr-29, Volume: 5 Topics: 5-Methylcytosine; Adult; Aged; Binding Sites; Biopsy; Cardiovascular Diseases; Cohort Studies; Cytosine; DNA; DNA Methylation; Electrophoresis, Capillary; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydralazine; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; RNA, Untranslated; Uterine Cervical Neoplasms; Vasodilator Agents	2005

Article

Year

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.

BMC cancer, 2005, Apr-29, Volume: 5

Topics: 5-Methylcytosine; Adult; Aged; Binding Sites; Biopsy; Cardiovascular Diseases; Cohort Studies; Cytosine; DNA; DNA Methylation; Electrophoresis, Capillary; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydralazine; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; RNA, Untranslated; Uterine Cervical Neoplasms; Vasodilator Agents

2005